Tech Company Financing Transactions

Latigo Biotherapeutics Funding Round

Latigo Biotherapeutics, based in Thousand Oaks, secured $135 million from 5AM Ventures, Foresite Capital and Westlake Village BioPartners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1300 Rancho Conejo Blvd. 305
Thousand Oaks, CA 91320
USA

Phone

Undisclosed

Website

www.latigobio.com

Email Address

[email protected]

Overview

We are a clinical-stage company developing innovative non-opioid pain medicines with best-in-class profiles. Reducing pain lowers stress and facilitates healing. There is a large unmet need for a new class of medicines to treat pain, as the standard of care for pain has remained unchanged for decades.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Desmond Padhi

        

Vice President

Holly Carlisle

        

Vice President

Mike Kaufman

        

Vice President

Bryan Moyer

        

Browse more venture capital transactions:

Prev: 2/14/2024: Parlay venture capital transaction
Next: 2/14/2024: Go Autonomous venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary